Research Papers

25 of 95 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Discovery, validation, and prodrug design of an ACE2 activator for treating bacterial infection-induced lung inflammati…
Lu P; Leslie F; Wang H; Sodhi A; Choi CY; Pekosz A; Cui H; Jia H.
J Control Release (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caus…
Homaeigohar S; Liu X; Elbahri M.
J Control Release (Unknown)
Published: 2023
1/6 Transparent
Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation.
Seow HC; Cai JP; Pan HW; Luo C; Wen K; Situ J; Wang K; Cao H; Leung SWS; Yuan S; Lam JKW.
J Control Release (Unknown)
Published: 2023
2/6 Transparent
Funding Declared
Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures.
Meulewaeter S; Nuytten G; Cheng MHY; De Smedt SC; Cullis PR; De Beer T; Lentacker I; Verbeke R.
J Control Release (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Recent advances in respiratory immunization: A focus on COVID-19 vaccines.
He X; Chen X; Wang H; Du G; Sun X.
J Control Release (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery.
Wang H; Qin L; Zhang X; Guan J; Mao S.
J Control Release (Unknown)
Published: 2022
2/6 Transparent
Funding Declared
Bioelectronic cell-based device provides a strategy for the treatment of the experimental model of multiple sclerosis.
Audouard E; Michel F; Pierroz V; Kim T; Rousselot L; Gillet-Legrand B; Dufayet-Chauffaut G; Buchmann P; Florea M; Khel A; Altynbekova K; Delgaldo C; Escudero E; Soler ABA; Cartier N; Piguet F; Folcher M.
J Control Release (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Strengthening scientific credibility against misinformation and disinformation: Where do we stand now?
Jeng W; Huang YM; Chan HY; Wang CC.
J Control Release (Unknown)
Published: 2022
2/6 Transparent
Funding Declared
Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM.
J Control Release (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Peritoneal M2 macrophage-derived extracellular vesicles as natural multitarget nanotherapeutics to attenuate cytokine s…
Wang Y; Liu S; Li L; Li L; Zhou X; Wan M; Lou P; Zhao M; Lv K; Yuan Y; Chen Y; Lu Y; Cheng J; Liu J.
J Control Release (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Multimeric RNAs for efficient RNA-based therapeutics and vaccines.
Kim D; Han S; Ji Y; Moon S; Nam H; Lee JB.
J Control Release (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Lung targeted liposomes for treating ARDS.
Arber Raviv S; Alyan M; Egorov E; Zano A; Harush MY; Pieters C; Korach-Rechtman H; Saadya A; Kaneti G; Nudelman I; Farkash S; Flikshtain OD; Mekies LN; Koren L; Gal Y; Dor E; Shainsky J; Shklover J; Adir Y; Schroeder A.
J Control Release (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
mRNA vaccines for COVID-19 and diverse diseases.
Hussain A; Yang H; Zhang M; Liu Q; Alotaibi G; Irfan M; He H; Chang J; Liang XJ; Weng Y; Huang Y.
J Control Release (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The economic challenges of new drug development.
Roope LSJ.
J Control Release (Unknown)
Published: 2022
2/6 Transparent
Funding Declared
Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy.
Mpekris F; Voutouri C; Panagi M; Baish JW; Jain RK; Stylianopoulos T.
J Control Release (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery.
Maeki M; Uno S; Niwa A; Okada Y; Tokeshi M.
J Control Release (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Non-viral vectors for RNA delivery.
Yan Y; Liu XY; Lu A; Wang XY; Jiang LX; Wang JC.
J Control Release (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Potential next-generation medications for self-administered platforms.
Chen CH; Cheng CM.
J Control Release (Unknown)
Published: 2021
1/6 Transparent
Funding Declared
BiTE secretion from in situ-programmed myeloid cells results in tumor-retained pharmacology.
Hao S; Inamdar VV; Sigmund EC; Zhang F; Stephan SB; Watson C; Weaver SJ; Nielsen UB; Stephan MT.
J Control Release (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE).
Parhiz H; Brenner JS; Patel PN; Papp TE; Shahnawaz H; Li Q; Shi R; Zamora ME; Yadegari A; Marcos-Contreras OA; Natesan A; Pardi N; Shuvaev VV; Kiseleva R; Myerson JW; Uhler T; Riley RS; Han X; Mitchell MJ; Lam K; Heyes J; Weissman D; Muzykantov VR.
J Control Release (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
RBC-hitchhiking chitosan nanoparticles loading methylprednisolone for lung-targeting delivery.
Ding Y; Lv B; Zheng J; Lu C; Liu J; Lei Y; Yang M; Wang Y; Li Z; Yang Y; Gong W; Han J; Gao C.
J Control Release (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency.
Anderluzzi G; Lou G; Woods S; Schmidt ST; Gallorini S; Brazzoli M; Johnson R; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y.
J Control Release (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Rational preparation and application of a mRNA delivery system with cytidinyl/cationic lipid.
Li L; Long J; Sang Y; Wang X; Zhou X; Pan Y; Cao Y; Huang H; Yang Z; Yang J; Wang S.
J Control Release (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Self-assembled polymeric micelle as a novel mRNA delivery carrier.
Ren J; Cao Y; Li L; Wang X; Lu H; Yang J; Wang S.
J Control Release (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2.
Kamat S; Kumari M; Jayabaskaran C.
J Control Release (Unknown)
Published: 2021